The long-awaited answers to the dHealth Community’s Questions
Transcript of the YouTube Video
Filip:
Hello everyone, and welcome to the long-awaited dHealth AMA, where we will answer all the questions put forth by the community, no matter how long it takes!
I will be hosting the AMA and Eberhard Scheuer is joining me to answer all the inquiries.
I’m sure everyone in the community knows who Eberhard Scheuer is, as well as who I am, but let's do a brief introduction for anyone who has recently joined the dHealth community.
My name is Filip Milneršić, and I am a dHealth core team member performing in the role of the community lead. I also often perform in various other roles, such as technical writer, marketing specialist, etc.
Now, passing on to Eberhard, could you give us a short introduction of yourself?
Eberhard:
Thank you. Filip, I'm Eberhard Scheuer. I'm the founder of the dHealth Network. I'm originally a psychologist, as you all know. So that's why I'm interested in data sharing, research data, and incentivizing people to change their behavior, i.e sharing data, and I consider myself now as one of the custodians of the dHealth Network DAO.
Filip:
Awesome. Thank you very much. Since there are quite a few questions, I think some deserving very thorough explanations, I think it's best we dive right into all the questions that the community has put forth. So let's go with the first one, which is about centralized exchanges, and it is a multi-part question.
Why hasn't a centralized exchange listing been executed so far? Because there was one planned. What are the hurdles with regard to listing on exchanges, centralized exchanges, and when can we expect one?
Eberhard:
Okay, so right now we are only listed on Osmosis, which is the biggest DEX in the Cosmos ecosystem. There's another one, another significant one, which is Kujira. But right now it's only Cosmos. To be honest, another DEX only makes sense if we extend to another ecosystem, another blockchain that has its own DEXes. So when we come to the centralized exchange listing, I mean, you already saw in the living paper that this was only planned once we have enough liquidity to do so. Here we are looking at, if we go for a decent exchange, at least 100,000 US dollars for fees, plus the liquidity that you have to provide, and market making. So we are on it. And there's one interesting development we are probably having a grant coming in from a partner, from another ecosystem, who wants to cooperate on decentralized science aka DeSci, because this is one of the buzzwords these days. That should enable us to do a listing on a centralized exchange.
Of course, I know that it is later than we expected, but still, despite all the resistance, I think we should manage it at the beginning of 2025, most likely January, let's put it that way. I know that's much later than expected, but I think with all the good news with the partnerships coming up right now, I would say that we can hold it this time.
Filip:
Excellent, good news.
Eberhard:
In that context, we could have also sold DHP, but DHP right now, in my opinion, it's heavily undervalued, so it wouldn't make sense to sell DHP just for a listing, because we would have to sell over the counter such a big amount that this would already threaten the decentralization of the whole system. This is not an option. The money has to come from partnerships and grants. We're working on that.
Filip:
Okay, let's go to the next question. The second question, again, a multi-part question.
So I hope you will try to memorize the questions:
Will the new tech releases utilize the token?
Are there customers adopting the new tech release?
Will this process be transparent, as in, who is adopting this new technology release that we announced that goes together with the airdrop,
Will this tech release be exclusively B2B, or can the community help the team in its growth?
You can answer the first question, then, I can repeat the next question when you answer one, or however you feel like answering.
Eberhard:
I see the questions, so I can repeat them also because, basically those are four questions. So of course, the new tech releases will utilize the DHP as a token, as a utility token. Everything else wouldn't make any sense. I mean, creating new tokens would not help the dHealth and DHP situation. So of course, DHP is an incremental part of any new project or current project on dHealth. Then we come to the customer using tech release. I know it's kind of who are the customers right now, there's so many companies on the website, so let's be honest here.
Who's the customer in the context of a blockchain in general, or a DAO? So we have worked, or are still working with organizations and companies, but let's be honest. I mean, the same situation with DeFI. Do the banks work with Blockchain? No, they don't. They're just some companies testing it. And the same is happening in blockchain, in healthcare, partners are testing it. We have partners like Swiss TPH that are building and continue to use it. Pharma companies have worked with us. They're currently due to the DeSci hype re-evaluating it, but this, in my opinion, is taking a long time to get to significant transactions.
So our focus right now is, as DeSci says, decentralized science, which is mainly citizen science, so we need to give individual users a good value proposition. And I think now with the features of data sharing, disguising your privacy, sharing data in an encrypted way for analysis is all down the alley of individual users sharing their data and also protecting the data, which in turn, then will again engage pharma companies. As a matter of fact, I will have a call next week with one of the large pharma companies offering weight reduction on the world market.
I had a call with Swiss Post providing the National Patient Registry this afternoon, so with all the discussion going on right now, we have had more inquiries in the last four weeks than we had in the last two years, which makes me very optimistic, in combination with the grants that we can move things forward here, and of course, all the partners, if they work directly with us, then they will be transparent.
But also you have to be aware that dHealth is open. Everybody can use dHealth like an open network, upload their own smart contracts. They don't even have to ask us. And that would, in my opinion, be the ideal scenario that we have partners that we don't even know about.
They're just using the platform for their benefit.
Filip:
Yeah, exactly as it was envisioned at the very beginning of the dHealth project where dHealth is the platform, the architecture used by healthcare participants and stakeholders.
Okay, and the last question of this multi-part question is, can the community help the team in its growth? Then the answer is definitely yes, by creating their own solutions that are obviously focused on, what did you call it, citizen scientists?
Eberhard:
Citizen science? That's a term where people take the initiative to collect data and then analyze the data and share the data. One of the examples is patient groups, where they themselves use dHealth as a data collection platform, and then the data that's being collected through the app Centiva which can be analyzed by those patient organizations.
There can even be one single patient with a rare disease. So actually, we're going to productize Centiva now so that everybody can use it from the outside without even having to talk to us.
Filip:
Excellent. Great news. Okay, let's go to the next question, the third question out of, I think 22 so. This is a simple one. I would say, is it possible to obtain DHP by paying USDC or USDT directly to dHealth management instead of purchasing DHP through the DEX?
The question is set forth because as the community member asking the question states, the liquidity on the DEX is thin resulting in high slippage. So yeah, is this possible?
Eberhard:
Yeah, I think OTC deals in general, and over-the-counter sales are possible. Probably not with management there in the DAO, there is no management, so that's just stakeholders, and guardians, and I think some people are in the project for a long time, so they might want to sell some of it.
But I would actually prefer if OTC deals goes through the association so that we can actually use that crypto for listing purposes. So, I mean, it's one thing. If tokens change hands among peers, that's totally fine. Nobody can prevent people from that, but right now, in this situation, I would rather have those deals go through the association.
And you can, actually, with the new Osmosis feature of limited orders, also do the same. You put an order and say, for example, I want to buy a million DHP for that price. So you don't have to buy on the spot or sell on the spot, using the existing liquidity pool. You're just putting out an order. And that's not related to the current liquidity in the pool, which is, I have to admit, quite low compared to other projects. But with the partnerships coming up, there will be a pool of DHP with another cryptocurrency out of the Cosmos universe, so that should be resolved to some extent.
Filip:
Okay, good to know. The next question is, we kind of touched briefly on this already. So what will happen to the Centiva Life app and do you plan to release a new version?
Eberhard:
Centiva is already running on the Cosmos network, but in order for people to use it without us having to help them onboard, it definitely needs some brushing up. It needs some upgrades. And with the whole DeSci discussion, the Centiva came back into our focus, and that's actually treatment monitoring, what we have been asked for lately the most, actually.
So definitely, I know we have before the pandemic, we have positioned that as a strategic area, but then during the pandemic, we kind of lost the focus on that. And right now, and you also see that on the website, it's one of our three key pillars of applications, because that's the easiest way of generating data, and the most valuable data, which is everyday, real-world data.
Because then you can connect it to clinical trial data, which is just a very small snapshot of your life. And this is actually requested the most right now.
Filip:
And when will you release the new app?
Eberhard:
I would say, depending on how things are going, definitely February. So that's 8 to 12 weeks from now.
Filip:
Okay, exciting, that’s relatively soon. And then the other part of this question is about other ongoing projects that we had specifically, what's happening with the rabies project, what's happening with the medical marijuana project, UPD8 and the donor card project.
Eberhard:
Okay, so the rabies project comes from a research collaboration with the European Union and Swiss TPH, and it's happening in Africa, Mali and Ivory Coast. It's implemented ready and working in Ivory Coast. Mali has some cultural problems because going from paper to digital seems to be still an issue.
But the good news is it's running on the Cosmos-based dHealth Network, and is actually running and just talked to Professor Jakob Zinsstag, who is the primary investigator in that and also the one who transferred that into a regular application on the ground. He said, to his knowledge, this is the first implementation where human and animal data are handled in the same project, because rabies, as you know, is transmitted mainly by dog bites and tracking, and this is where dHealth is being used. The tracking of the medication is implemented in that so they can always see in the logistics hub where the medication is. And the primary result is there's no medication disappearing. So the whole purpose is fulfilled. It's ongoing. It's one of the projects where I have to say, for a long time, it's working well. Academics, we noticed, are more open to trying new stuff, and they don't have to follow business reorganizations and so on. Okay, the next project, is the marijuana medical project. This is something that came originally from one of our original team members, Isaac, and it's still ongoing.
That's all I can say.
All right, UPD8 health. That's the health-to-earn application which some of you still use. We have not migrated it yet because it takes some resources, and right now, there's no sponsor for the incentives. So why am I saying that? Because if we just give our tokens, that's nice, but it just increases inflation. So if we continue that, we need to have a partner that can drive the project, and I invite anybody from the community to also look into if they want to drive that project. It's open. Nobody owns that project. It's part of the dHealth community project.
So if you're interested in developing that further, you can just come talk to us, talk to our developer Son, who created that, and we can migrate it quite easily, to the Cosmos-based dHealth blockchain. Last week we had an interesting call with developers who develop Telegram Mini Apps. So very easy to develop, I would say migrating UPD8.HEALTH as a telegram mini app would open it to a large user community. We just have to make sure that people are real people and not bots. And you don't necessarily have to connect Mini Apps to the ton blockchain, which is a separate entity, but it's, of course, closely integrated into telegram Mini Apps. You can also trigger payouts on other blockchains, like dHealth. The third and last project that was asked for was the donor card project.
Filip:
Yes, yes.
Eberhard:
One of the developments we have done when you look on the website is data sharing with multi-party computing thresholds signature security. So this is a very high-end technology, but what it does, in the end, is you can assign other people as guardians of your data, and if you, for example, in the case of organ donation, if you are unconscious, if you're actually brain dead and cannot sign transactions to release the data, such as organ donor wish your relatives, or people that have the attribute in the digital identity as a doctor can release that data and look what your wish is.
What the issue is if the card is put on the blockchain so that everybody can see it. That's kind of calling all the data protection guys of this world to us. So we had to develop that special data-sharing process, which I would say is unique in a sense, and will also attract more partners. In the end, partners with the organ donor card project are Paris Transplant Group and OrganX, they are waiting for it to be released, and the release as we said, of the data sharing is with the airdrop next week.
So then they have to decide how to move that forward from their side, and then everything will be done. So this is basically in their hands because of credibility. We don't have the credibility for organ donation cards, although I myself worked in that space for a couple of years.
Filip:
Yeah, so the ball is in their court, as they say, right, yeah. Alright. Thank you for the in-depth explanations, let's go to the next one, the fifth question out of twenty-two. So what roles are expected of the community and token holders who are part of the DAO?
Eberhard:
So in the interest of time, I'm now answering questions much shorter, and I won't go into such detail anymore. Being part of the DAO means to bring project ideas, develop yourself, and bring partners. I mean, as a DAO member, you can start developing on dHealth, and you can bring in proposals, and the community then has to vote on the proposal.
Filip:
Okay, very straightforward, next question. What do you think makes dHealth different from other medical blockchain projects, for example, MediBloc and VitaDAO?
Eberhard:
They have a specific purpose. VitaDAO, for example, finances certain research projects. Mediblock is for medical records. I saw that they just had revived the whole website, the whole project lately, also built on Cosmos, by the way. So yeah, they have one specific purpose. We want to open and enable others to build their projects, while MediBloc and VitaDAO are project-specific.
So I think that's the main difference. Some of the other projects out there are just smart contracts or even only one token. So, that's why they differ from our holistic approach.
Filip:
Okay, the next question is actually first a statement followed by a question. It goes as follows: just recently, Binance Labs announced its investment in Bio Protocol. We may see more investments in collaboration between science and medical fields and blockchain technology such as these, which we've been discussing. So the question is, are you prepared for that?
Eberhard:
Of course. Well, we are actually on it. As I said, we are working on a partnership that we hope we can announce next week or certainly before Christmas, which will also bring things forward.
But one thing you have to notice, who's investing here? It's Binance Labs into Bio Protocol. What does it mean? It's crypto guys investing in blockchain healthcare. You will not find an organization like a big pharma company investing in a blockchain project for regulatory reasons. That's just the bitter truth. So here we see Binance Labs, crypto guys investing in DeSci, and I mean, ever since CZ and Vitalik discussed DeSci my phone never stops ringing.
Filip:
So the next question is, now that smart contracts have been introduced, how will the code be audited for soundness?
Eberhard:
I mean, Cosmos itself is permanently auditing the SDK and so on. However, smart contracts that you put on any layer-1 blockchain have to be audited by the creator of the contract. If we create a contract, then, of course, it will be audited by one of the known companies. But in general, the creators of the smart contracts are responsible for auditing the contract, giving the trust that they do not have some malicious code in that. So this is the answer to that: we are not auditing. We are not an auditor institution for other people.
Filip:
So, in other words, dHealth will hire a legitimate third party for auditing if we are the ones deploying a smart contract on the dHealth network.
Okay. The next question is, what realistic market cap of the DHP token does the dHealth team expect after all the important milestones such as the release of new technology, AirDrop on Cosmos, negotiations with centralized exchanges, etc.. I did clarify when this question was dropped in the community chat that we cannot speculate, but perhaps you can share your own personal opinion, since the community is inquiring.
Eberhard:
Well, the fact is that dHealth, at least in my impression, is undervalued. So something has to happen, and this is certainly partnerships, centralized exchange listing, and then I mean easily, the valuation will go up times 10x, so then it's even undervalued, let's be honest. My ambition is five cents per token at least.
Filip:
Next question: we already touched briefly upon this, but we can go through it fast, so it goes as follows; “when we have completed the rewriting of the [existing applications] code”. We can just go through this again briefly. Centiva, you said February, if I'm not mistaken, right? For UPD8, there is no current set date. It depends on interest. So if we have an interested sponsor, partner, or somebody else, it can be done in a week or two, right? Okay, and are there any other code rewrites planned regarding the old applications & projects that we had?
Eberhard:
I mean those are the two applications that we are continuing, the new ones like the data-sharing are already on the Cosmos-based dHealth blockchain.
Filip:
Okay. Next question, when will an update for the roadmap be published?
Eberhard:
There will be no concrete long-term roadmap anymore because it's just not feasible.
It depends on so many things happening. As you saw, I updated the living document, it's reduced to what comes in the next two to three months. One is the airdrop that should happen next week. We wanted to do it this week, but then Thanksgiving was yesterday. Also part of our team is in Lebanon. The war started and ended, so that kind of got in the way.
So it's happening next week, the bridging of dHealth, into a larger ecosystem, will happen, hopefully, this year, that's depending on the partnership agreement. Integration of data storage will be decentralized. A data storage solution will also be one of the next steps, which is set for January.
It depends on the technical integration as well as communication between dHealth and the partner.
So that will cover the next, let's say, eight weeks, anytime, if we have the funds, we will prioritize centralized exchange listing.
Filip:
Okay. Next question is, what will happen to the DHP that was not migrated from the Symbol-based blockchain?
Eberhard:
There's still time until the end of April 2025 to migrate it. What will not be migrated, will go to the community fund. And you should also remember that we burned 200 million DHP in the migration process to leave more room for staking. So this will, I would say, also be the amount that will not be migrated from the old chain.
Filip:
So will the part of it be burned and the part assigned for community funds, or all DHP that was not migrated, will go towards the community funds?
Eberhard:
No, all the DHP that we pre-mined. I mean, when we started, we released a certain amount of DHP. That was the number of DHP on the legacy chain minus the 200 million that we burned. What's left until the migration day will all go towards the Community Fund.
Filip:
Just to clarify, our dHealth DAO members, or in other words, token holders, can vote on how these funds will be used, correct?
Eberhard:
DAO members can already submit proposals, and then we have a community vote on that.
I personally recommend, if you want to submit a proposal, you should reach out to us beforehand so we can actually make sure, if it makes sense, that it will be known to the community because the voting window is 72 hours, if you just put it there, I doubt it that it will be accepted, so we have to communicate it to the community via our channels beforehand, before the 72 hour voting period begins.
Filip:
Next question, the 13th question, what is the status of technology related to managing patients' personal information?
Eberhard:
The status is that for one, you have to store it on your site, but to share it, it will be a pointer to the data, and temporarily, the data you want to share in an encrypted way will be put on decentralized storage for the period that you define, and then disappear. And that will be with our new partner which I cannot name right now, but there's a limited number of decentralized storage providers out there, so you can make wild guesses. That will be January, or February, I would say.
Filip:
Okay, next question.
Similar to the non-migrated DHP question. So what will happen to the old chain DHP, held by inactive accounts that may have been lost in the initial airdrop? So I guess this is asking about unclaimed DHP from the initial AirDrop?
Eberhard:
Yeah, I mean, those are accounts that are not transferre,d and they will go to the community fund.
Filip:
Okay. Next question: what is the expected timeline for the release of health-to-earn following the transition to Cosmos? Additionally, could you provide information about other features currently under development?
So let's address the first part of the question, which has already been addressed. Health-to-earn relates to both Centiva and UPD8. You already provided a timeline for both. So I'll just repeat Centiva, January or February, and UPD8 depending on interested partners and sponsors, but it can be done fast if there is interest for a partnership or sponsorship.
Eberhard
I mean, we talked about Centiva and the data-sharing multi-party computing stuff. There's one feature coming up as well that's homomorphic encryption. What does it mean? It means that other people can run analysis on encrypted data, without having access to the raw data.
You might remember all the discussions around DNA data if you put it in blockchain, or people can actually analyze the raw data. Nobody can prevent them from taking the data. Once you have the DNA data of a person, you know all about that person. So you should if someone is asking, even if it's Elon Musk, you should not release or share your DNA data for AI. So, homomorphic encryption, just in short, you can encrypt your data, put it on temporary storage, someone or some organization can analyze it, get the insights, but has never access to the raw data, and then you can remove it, and nobody has access anymore.
So this is our solution, and I'm expecting, that's the use case where we are expecting a lot of corporate interest, but we're not there yet.
Filip:
Amazing stuff, I was personally mind-blown when I heard from our developers that it's been successfully created. Very excited, very excited. Okay, the question is, are there any other features? So obviously, there is this homomorphic encryption. Is there anything else that is currently under development, at this moment, not planned, but right now.
Eberhard:
Well, as far as I understand, the question extends to observational studies in epidemiology, and it is a yes because of creating data, real-world data, and sharing it. This is kind of revived as a movement right now. So technically, yes, and I'm also interested in driving that forward.
Filip:
Yeah, this is the next question. Would researchers in the future be able to request data from unique individuals globally who have their health data on the dHealth and then use the data, for example, in observational studies in epidemiology? But it's also connected to the question before it, which was asking about other features being developed right now, and this includes the homomorphic encryption you mentioned. But yeah, I think we answered both questions, so we can continue.
The next question is, then, what happened to your relationship with your previous partner Bowhead Health?
Eberhard:
Bowhead kind of does very little with Blockchain. They moved into specific app development, but actually, we are having an extensive discussion next week with them. As I said, they're from the US, so Thanksgiving got in the way, so we have a discussion next week about common projects.
Filip:
Okay, next question, just for those watching, we have 6 more questions.
Can the team elaborate as much as possible on current partnerships about healthcare, are old ones still in place? Are some no longer possible? Have there been new ones? So basically, partnerships, what's the current situation?
Eberhard:
Pharma partnerships are on hold, the old ones because of different reasons, mainly the pandemic came into the way. We had pandemic-related partnerships during the pandemic. We had a discussion with one of the large Danish pharma companies, with still friendly terms with Roche and Lilly, who were node operators. They're still using some of our stuff, but the old stuff. So active partnerships are the universities, Swiss TPH, as I said, then the University of Zurich. Also, the University of Applied Sciences and Arts Northwestern Switzerland, is actually helping us quite a lot in the security of homomorphic encryption, and they're actually actively using our Centiva tool.
Filip:
Then the next question is, what will be the airdrop criteria? If it can be publicly announced at the moment, is it possible to get in by buying Cosmos-based assets from now on.
Eberhard:
The criteria are: the amounts of ATOM staked, and recent activity in the cosmos Hub account. So I would say, I mean, given that we are not airdropping a large number of DHP, it doesn't make sense for anybody in the community right now to increase their stake in ATOM in order to get DHP, because we're looking at a cut off of 25,000 accounts, each getting a couple of hundred DHP.
So that's not really worth making an effort, because we don't do the airdrop to spread the token that already exists for a long time. We do that to enable the people to have enough DHP to test the new features. That's what we are interested in, and also making the community aware, because we're going to get the retweet from Cosmos, and also from the airdrop guys.
Filip:
Okay, great. Good to know, because this is also the question I've been receiving in the community chat. So I'm glad we can kind of clear that up. People were wondering if they should be buying ATOM to get DHP, so I'm glad you clarified that it's better to just get the DHP instead of ATOM, if one wants to get more DHP. Okay, so the next question is, in what situations are community funds used?
Eberhard:
The community funds are there to support projects, concrete projects. We already mentioned that if you have a project, talk to us and then there must be a community vote in order to use the community fund.
Filip:
So, in other words, whatever the community deems appropriate, and the dHealth team cannot affect this in any way. If the community decides to use DHP from the community funds for something, we as custodians, cannot do anything about it, correct?
Eberhard:
No, I mean, there's an automatism that the payout will be if the vote gets accepted there. It's automatic.
Filip:
Yeah, I wanted to clarify this, because dHealth is DAO now, which was planned and announced from the beginning, and I often get these sorts of questions which makes it seem that people don't understand that this is how it is now, the dHealth team is just the custodian.
Okay, I have a question: Does the team have plans to get involved in the open data space?
Eberhard:
Well, I guess we touched on that already. The new features of data sharing enable that, and any initiative is welcome. I think open data space is one of the great things about the internet and connecting people so that we don't have to give the data to some centralized entity that we have to trust. So of course, we support that.
Filip:
Okay, so next question, it's sort of like a statement followed by questions. So it says, it's great to see innovative technology being implemented. How much human resources does your company, former Foundation, allocate to such technology development. Are there plans to add resources to accelerate dApps development?
Eberhard:
I would love to dedicate more than four to five people at the moment, but this will change with partnerships, of course. But as the nature of the DAO is, I mean, people can always do their stuff, so we have to basically disconnect ourselves from traditional thinking where everything is centralized and has to be driven by a team. I know that's much easier for a lot of people to do and wait for something to happen. So I would love to see people with their ideas be involved more.
Filip:
Okay, and the final question, the question, is, again, a statement followed by a question.
So it says: this may be a question that cannot be answered because of confidentiality reasons. The amount of funds raised in the IDO was small, and it is likely difficult to raise funds through a token sale at the current token price. So the community member that asked the question, feels that the project is going ahead because of an injection of funds from investors. So the person is wondering, is that the case? And if so, what can we share?
Eberhard:
Yeah, I mean, I saw comments in Telegram that doubted the dedication of the people involved in driving it forward. I can reassure you that with very limited resources, people are very dedicated, although from the outside, they think we're not communicating, and we're not doing something. That's definitely not the case.
I would say that with the strategic partnerships, things will become much more dynamic. And as I said, this should happen within the next two weeks so that we can actually invest not just time, sweat and blood, but also pay more people to move things forward faster. And this will also almost certainly cause the token price to go up.
Filip:
Thank you for sharing, and this brings us to the end of the questions. It's been quite an informative journey. Before we conclude, do you have anything to add?
Eberhard:
Yeah, I have to add that I'm very thankful for community members being so patient and supportive, and we are all planning on not to disappoint you with your patience and support.
So, wait for the partnership announcement and for things to develop quite dynamically shortly.
Filip:
Excellent, excellent. Thank you, Eberhard, and once again, thank you, our dear community members. If you have more questions related to the answers provided in this AMA please drop them in the Telegram cha,t and we will tend to them as soon as we can.
See you all in the next AMA, bye-bye!
